Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
11.56
0.75
6.49%
Share Warrants & Outstandings
Total Reserve
33.10
31.16
1.94
6.23%
Shareholder's Funds
45.42
42.72
2.70
6.32%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.93
1.45
155.91%
Secured Loans
2.38
0.00
2.38
0.00%
Unsecured Loans
0.00
0.93
-0.93
-100.00%
Deferred Tax Assets / Liabilities
-4.37
-0.03
-4.34
-14,466.67%
Other Long Term Liabilities
0.00
0.05
-0.05
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
0.95
-2.82
-296.84%
Current Liabilities
Trade Payables
5.59
1.25
4.34
347.20%
Other Current Liabilities
1.74
3.27
-1.53
-46.79%
Short Term Borrowings
5.02
0.11
4.91
4,463.64%
Short Term Provisions
0.01
0.00
0.01
0.00%
Total Current Liabilities
12.37
4.63
7.74
167.17%
Total Liabilities
55.92
48.30
7.62
15.78%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
8.36
18.82
225.12%
Less: Accumulated Depreciation
8.48
2.39
6.09
254.81%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
5.96
12.74
213.76%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.68
-0.63
-92.65%
Long Term Loans & Advances
2.12
8.39
-6.27
-74.73%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
31.01
15.03
15.98
106.32%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
12.90
-4.68
-36.28%
Sundry Debtors
13.54
9.47
4.07
42.98%
Cash and Bank
0.73
3.42
-2.69
-78.65%
Other Current Assets
0.41
1.77
-1.36
-76.84%
Short Term Loans and Advances
2.00
5.72
-3.72
-65.03%
Total Current Assets
24.91
33.28
-8.37
-25.15%
Net Current Assets (Including Current Investments)
12.54
28.65
-16.11
-56.23%
Total Current Assets Excluding Current Investments
24.91
33.28
-8.37
-25.15%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
48.30
7.62
15.78%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
1.04
6.36
611.54%
Book Value per share (adjusted)
7.38
36.14
-28.76
-79.58%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024






